MTOR and neoplasm: Previous studies found that reduction of lactate levels correlates with tumour growth suppression in animals with chemotherapy, such as 5-fluorouracil, cyclophosphamide, or combined PI3K/mTOR inhibitor and temozolomide treatment [23, 24], implying that reduced lactate levels after therapy may result from decreased glycolysis and cell death.